Data Sheet 1_Sporoderm-removed ganoderma lucidum spore powder (S-GLSP) alleviates neuroinflammation injury by regulating microglial polarization through inhibition of NLRP3 inflammasome activation.pdf

Introduction<p>Sporoderm-Removed Ganoderma lucidum Spore Powder (S-GLSP), derived from the spores of the medically valued fungus Ganoderma lucidum, exhibits diverse pharmacological activities and shows considerable potential in the treatment of Alzheimer’s disease (AD). However, its underlying...

Descripció completa

Dades bibliogràfiques

Autor principal:	Wenli Li (337819) (author)
Altres autors:	Wei Huang (36889) (author), Peng Zhou (116747) (author), Yongchuan Yao (22679309) (author), Biao Cai (4288222) (author), Shu Ye (44563) (author)
Publicat:	2025
Matèries:	Pharmacology sporoderm-removed ganoderma lucidum spore powder Alzheimer’s disease microglial polarization neuroinflammation NLRP3 inflammasome
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!